Blog / Topics

Behavioral signals before diagnosis

14 guides, published between February 2024 and July 2026. What do patients and families search before a diagnosis, and how does VIOLET measure it?

Guides

  1. Spinal muscular atrophy behavioral data: parent search patterns before gene therapy

    July 1, 2026

    Parents of children with spinal muscular atrophy produce a distinct behavioral data trail in the months before gene therapy decisions. These search patterns reveal urgency, fear, insurance confusion, and treatment comparison needs that clinical systems never capture. SMA data from parent search behavior creates a real-time map of where families are in the decision window and what support they lack.

  2. Ehlers-Danlos syndrome behavioral intelligence and connective tissue disorder searches

    June 22, 2026

    Ehlers-Danlos syndrome takes an average of 10 to 12 years to diagnose. During that window, patients generate thousands of behavioral signals across search, community, and clinical data that no one is reading systematically. EDS data, connective tissue disorder behavioral signals, and hypermobility behavioral intelligence represent one of the most undertapped sources of pre-diagnostic insight in rare disease.

  3. POTS behavioral data and the autonomic disorder diagnosis gap

    June 22, 2026

    POTS patients wait an average of 4 to 7 years for a correct diagnosis, cycling through cardiology, psychiatry, and primary care before anyone names the condition. Behavioral data from search patterns, community forums, and wearable signals reveals a consistent pre-diagnosis fingerprint that the clinical system currently ignores. Understanding postural orthostatic tachycardia behavioral signals can close the autonomic disorder diagnosis gap before patients lose years to misdiagnosis.

  4. Amyloidosis behavioral signals: late diagnosis and the data gap

    June 21, 2026

    The median delay in cardiac amyloidosis diagnosis is 22 months, and in some subtypes it stretches past 34 months. Behavioral data from patient search patterns reveals a pre-diagnostic window filled with fragmented symptom queries, specialist-hopping signals, and misdiagnosis frustration. This gap is not just a clinical failure. It is a data infrastructure failure.

  5. PCOS behavioral data and the metabolic risk signal before diagnosis

    June 19, 2026

    Nearly one in three women with PCOS meets criteria for metabolic syndrome, yet the average diagnostic delay is 2 to 4 years. Behavioral data reveals that patients search for individual symptoms like weight gain, fatigue, and hair loss years before anyone connects them to polycystic ovary syndrome. PCOS metabolic risk intelligence can close this gap if we build the data infrastructure to capture it.

  6. DIPG parents search in weeks, not months: what the data shows

    June 16, 2026

    Approximately 300 children are diagnosed with diffuse intrinsic pontine glioma (DIPG) in the United States each year, and fewer than 1% survive five years. The behavioral data generated by their parents during the search for answers follows a pattern unlike any other cancer type: compressed timelines, extreme urgency, and a rapid pivot from symptom queries to clinical trial desperation. Understanding these pediatric brain tumor behavioral signals reveals both the cruelty of the disease and the structural failures of the systems meant to help families find options.

  7. Bone metastasis behavioral signals: what stage IV cancer patients search

    June 14, 2026

    Stage IV cancer patients with bone metastases generate distinct behavioral signals months before clinical milestones like hospice referral or treatment discontinuation. These signals cluster around pain management, life expectancy by cancer type, and end-of-life planning. Bone metastasis data reveals a patient population searching with urgency, specificity, and fear that current oncology content fails to address.

  8. BRCA2 vs BRCA1 behavioral intelligence: what mutation carriers search differently

    June 10, 2026

    BRCA1 and BRCA2 mutation carriers search for fundamentally different things online, and the divergence maps to real clinical differences in cancer risk, treatment options, and psychological burden. BRCA2 behavioral data reveals a population that searches later, worries about different organs, and engages with clinical trial content at lower rates than BRCA1 carriers. These behavioral signals represent an untapped intelligence layer for oncology teams, pharma, and research organizations.

  9. KRAS mutation awareness: what precision oncology patients search

    May 23, 2026

    KRAS mutations appear in roughly 25% of all human cancers, yet most precision oncology platforms treat patient search behavior around KRAS as background noise. KRAS mutation data, when mapped against behavioral signals, reveals where patients are in their treatment arc and what they will do next. This post covers what precision oncology patients actually search, what those signals mean for pharma and clinical trial teams, and why the data layer underneath matters more than the search itself.

  10. Head and neck cancer patient journey: behavioral data before first oncology consult

    May 6, 2026

    Head and neck cancer patients generate measurable behavioral signals weeks before their first oncology consult. These signals, from symptom searches to appointment delay patterns, represent a layer of patient intelligence that clinical systems never capture. Understanding this pre-clinical window changes how pharma, health systems, and researchers identify and reach patients earlier.

  11. Pancreatic cancer search behavior and early detection signals

    April 2, 2026

    Pancreatic cancer kills 80% of patients within a year of diagnosis because it is found too late. Behavioral data signals, scored and validated through frameworks like the Data Trust Index, could shift detection timelines from late-stage crisis to early-stage intervention.

  12. Behavioral intelligence for clinical trial recruitment in oncology

    March 3, 2026

    Clinical trial recruitment in oncology fails most patients before they ever hear about a study. Behavioral intelligence, powered by trusted data, can identify the right candidates at the right moment and close the gap between eligible and enrolled.

  13. The anxiety gap in cancer care: what patients search before they call a clinic

    February 19, 2026

    Before a cancer patient ever picks up the phone to call a clinic, they've already searched dozens of questions that reveal deep anxiety signals. Understanding cancer patient search behavior is the key to closing the gap between fear and care. VIOLET behavioral intelligence turns that hidden data into actionable insight.

  14. What VIOLET Sees: The Behavioral Layer of Cancer Before Patients Reach a Clinic

    February 28, 2024

    Before a patient steps into a waiting room, they search. They search at 2am when the anxiety is highest. VIOLET maps that invisible layer — the behavioral signal layer of cancer that exists before clinical presentation.

Where this lives in the product